InflaRx (IFRX) Current Assets (2016 - 2026)
InflaRx's (IFRX) quarterly Current Assets came in at $55.5 million in Q1 2026, down 38.38% year-on-year from $90.1 million in Q1 2025, and down 11.12% quarter-over-quarter from $62.4 million in Q4 2025.
InflaRx (IFRX) Current Assets (2016 - 2026) Analysis & Trends
InflaRx has disclosed Current Assets across 11 years of filings, most recently posting $55.5 million for Q1 2026.
- Current Assets for Q1 2026 came in at $55.5 million, down 38.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.5 million (down 38.38% YoY), and the FY2025 annual result was $62.4 million, down 18.46% from the prior year.
- Current Assets came in at $55.5 million for Q1 2026 at InflaRx, down from $62.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $138.8 million in Q3 2023 to a low of $55.5 million in Q1 2026.
- The 5-year median for Current Assets is $98.3 million (2024), against an average of $95.9 million.
- Peak annual rise in Current Assets reached 36.39% in 2024, while the deepest fall reached 41.76% in 2024.
- InflaRx's Current Assets stood at $99.4 million in 2022, then climbed by 18.51% to $117.8 million in 2023, then plunged by 34.99% to $76.6 million in 2024, then retreated by 18.46% to $62.4 million in 2025, then retreated by 11.12% to $55.5 million in 2026.
- The last three Current Assets figures came in at $55.5 million (Q1 2026), $62.4 million (Q4 2025), and $74.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 600.85 Mn |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | 55.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.49 Mn |
| Dec 31, 2025 | 62.43 Mn |
| Sep 30, 2025 | 74.20 Mn |
| Jun 30, 2025 | 74.90 Mn |
| Mar 31, 2025 | 90.05 Mn |
| Dec 31, 2024 | 76.57 Mn |
| Sep 30, 2024 | 80.85 Mn |
| Jun 30, 2024 | 98.32 Mn |
| Mar 31, 2024 | 111.86 Mn |
| Dec 31, 2023 | 117.78 Mn |
| Sep 30, 2023 | 138.83 Mn |
| Jun 30, 2023 | 122.20 Mn |
| Mar 31, 2023 | 82.01 Mn |
| Dec 31, 2022 | 99.38 Mn |
| Sep 30, 2022 | 109.63 Mn |
| Jun 30, 2022 | 119.65 Mn |
| Mar 31, 2022 | 116.38 Mn |
| Dec 31, 2021 | 109.45 Mn |
| Sep 30, 2021 | 118.23 Mn |
| Jun 30, 2021 | 159.19 Mn |